HARARE, Zimbabwe — Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection...

HARARE, Zimbabwe — Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection...

HARARE, Zimbabwe — Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection...

Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection hailed by global health...

Sunday Mail Reporter ZIMBABWE has approved the use of Lenacapavir, the long-acting injectable medicine used as a pre-exposure prophylaxis (PrEP), in a...

Gilead's ARTISTRY-1 success boosts shares as its once-daily bictegravir/lenacapavir combo proves non-inferior to complex regimens.

Gilead's ARTISTRY-1 success boosts shares as its once-daily bictegravir/lenacapavir combo proves non-inferior to complex regimens.

A "game-changer" immunisation that could save thousands of babies from a potentially deadly lung infection is sitting in the hands of Pharmac,...

Zuko Komisa The groundbreaking, twice-a-year anti-HIV injection, lenacapavir, has been approved for addition to South Africa’s Essential Medicines...

Zuko Komisa The groundbreaking, twice-a-year anti-HIV injection, lenacapavir, has been approved for addition to South Africa’s Essential Medicines...